(Q40651224)

22 September 2017

1 reference

title

Antisense therapeutics in haematological malignancies (English)

1 reference

22 September 2017

Kirkland MA

1

1 reference

22 September 2017

O'Brien SG

series ordinal

2

1 reference

22 September 2017

Goldman JM

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 July 1994

1 reference

British Journal of Haematology

22 September 2017

published in

1 reference

22 September 2017

volume

87

1 reference

22 September 2017

issue

3

1 reference

22 September 2017

page(s)

447-452

1 reference

An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Gene-marking to trace origin of relapse after autologous bone-marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Antisense technology for cancer therapy: does it make sense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Proto-oncogenes of the fos/jun family of transcription factors are positive regulators of myeloid differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

Human promyelocytic leukemia HL-60 cell proliferation and c-myc protein expression are inhibited by an antisense pentadecadeoxynucleotide targeted against c-myc mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

BCR-ABL antisense purging in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1994.TB08296.X

10.1111/J.1365-2141.1994.TB08296.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference